Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04876846 · ClinicalTrials.gov registry record · NA
Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity
A NA study, sponsored by Raydiant Oximetry.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT04876846: Completed NA study, sponsored by Raydiant Oximetry.
NCT04876846 is a NA study that has completed, run by Raydiant Oximetry. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04876846, a NA study, has completed, sponsored by Raydiant Oximetry.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to existing pulse oximeters, the calculations will be integrated into software in the final commercial product; (ii) obtain human measurements against which both computational models and animal data can be compared.
Interventions
- DEVICE GEN 3 Monitoring of Fetus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-04-24 |
| Est. Completion | 2025-11-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04876846
The ClinicalTrials.gov registry entry for NCT04876846 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Raydiant Oximetry, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GEN 3 Monitoring of Fetus is the first listed.
NCT04876846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04876846 about?
NCT04876846 is a clinical study titled "Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity". The overall purpose of this study is to evaluate maternal-fetal tissue light scattering properties. The objectives of the study are: (i) integrate established mathematical principles of oxygen saturation to model with increasing accuracy the "body in a body" problem of fetus in mother; similar to ex...
What is the current status of trial NCT04876846?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2021-04-24. Estimated completion is 2025-11-11.
What interventions are being tested in trial NCT04876846?
The interventions under investigation include: GEN 3 Monitoring of Fetus (DEVICE).
Who is sponsoring clinical trial NCT04876846?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.